IRIS
TOMMASINI, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.076
EU - Europa 3.474
AS - Asia 1.544
SA - Sud America 935
AF - Africa 58
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.044
IE - Irlanda 1.007
BR - Brasile 851
SE - Svezia 840
SG - Singapore 588
CN - Cina 560
UA - Ucraina 492
DE - Germania 355
IT - Italia 192
FI - Finlandia 187
GB - Regno Unito 171
VN - Vietnam 141
IN - India 62
AT - Austria 59
RU - Federazione Russa 43
PL - Polonia 29
TR - Turchia 27
AR - Argentina 24
FR - Francia 22
HK - Hong Kong 22
IQ - Iraq 22
MA - Marocco 20
BE - Belgio 18
IR - Iran 16
MX - Messico 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
VE - Venezuela 14
BD - Bangladesh 13
EC - Ecuador 13
PK - Pakistan 11
ZA - Sudafrica 11
AZ - Azerbaigian 10
CA - Canada 9
TN - Tunisia 9
CL - Cile 8
CO - Colombia 8
KE - Kenya 8
AU - Australia 7
NL - Olanda 7
UY - Uruguay 7
ID - Indonesia 6
IL - Israele 6
OM - Oman 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
RS - Serbia 5
EG - Egitto 4
EU - Europa 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
PY - Paraguay 4
AL - Albania 3
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
JP - Giappone 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
SN - Senegal 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.101
Salva come PNG Salva come JPEG
Città #
Dublin 1.007
Jacksonville 946
Chandler 659
Nyköping 502
Singapore 334
Beijing 208
Dearborn 203
Ashburn 167
Princeton 166
Cambridge 161
Medford 152
Dong Ket 140
Des Moines 120
Boardman 109
Ann Arbor 83
Messina 81
Lancaster 69
Jinan 58
Vienna 56
The Dalles 55
Woodbridge 51
Wilmington 49
São Paulo 47
San Mateo 41
Shenyang 40
Los Angeles 38
Pune 37
Rio de Janeiro 31
Tianjin 30
Warsaw 29
Helsinki 27
Nanjing 26
Belo Horizonte 25
New York 25
Hangzhou 24
Augusta 22
Hong Kong 21
Brasília 20
Bremen 20
Nanchang 20
Haikou 19
Brussels 18
Leawood 18
Munich 18
Hebei 14
Tashkent 14
Zhengzhou 14
Brno 13
Campinas 13
Ningbo 12
Porto Alegre 12
Ardabil 11
Curitiba 11
Baku 10
Nuremberg 10
Edinburgh 9
Guangzhou 9
Salvador 9
Taiyuan 9
Auburn Hills 8
Baghdad 8
Fuzhou 8
Houston 8
Hyderabad 8
Jiaxing 8
Manaus 8
Nairobi 8
Norwalk 8
Ottawa 8
Saint Petersburg 8
Seattle 8
Taizhou 8
Casablanca 7
Fortaleza 7
Francofonte 7
Monmouth Junction 7
Montevideo 7
Osasco 7
Seropédica 7
Washington 7
Agrigento 6
Betim 6
Clearwater 6
Dhaka 6
Frankfurt am Main 6
Goiânia 6
Muscat 6
São Bernardo do Campo 6
Ankara 5
Bauru 5
Belgrade 5
Catania 5
Caxias do Sul 5
Contagem 5
Cotia 5
Guarulhos 5
Istanbul 5
Joinville 5
Juiz de Fora 5
Kunming 5
Totale 6.410
Salva come PNG Salva come JPEG
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 174
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 146
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 115
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 111
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 92
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 89
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 86
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 86
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 86
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 84
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 84
Analytical profile and release of lonidamine from pharmaceutical formulation 82
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 82
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 82
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 81
Anticonvulsant agent: enhancement of physicochemical properties 81
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 79
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 79
Nanotherapeutics for anti-inflammatory delivery 79
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 78
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 78
Chitosan nanospheres containing cyclodextrins for idebenone delivery 78
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 77
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 77
Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation 77
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 76
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 76
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 75
B-Cyclodextrin conjugates for sustained release of drugs 75
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 75
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 74
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 74
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 73
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 73
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 73
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 72
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 72
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 72
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 71
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 71
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 71
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 70
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 70
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 70
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 70
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 70
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 70
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 70
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 69
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 69
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 68
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 68
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 68
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 67
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 67
Solid-state study of polymorphic drugs: carbamazepine 66
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 66
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 66
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 66
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 64
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 64
Biodegradable microparticles as carrier for moxifloxacine 64
THE COORDINATION CHEMISTRY OF 1,4 BENZODIAZEPINES.HEAVY METAL COMPLEXES OF PSYCOTHERAPEUTIC DRUGS. 64
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 64
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 64
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 63
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 63
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 63
Determination of fludarabine in a pharmaceutical formulation by LC 63
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 63
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 62
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 62
METODI PER LA VALUTAZIONE DIMENSIONALE DI PARTICELLE DI POLVERI DI IMPIEGO FARMACEUTICO.Nota IV. 62
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 61
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 61
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 60
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 60
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 59
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 59
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 59
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation 59
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 59
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 59
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 58
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 58
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 58
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 58
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 58
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 57
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 57
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 57
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 57
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 57
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 57
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 57
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 57
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 56
SPECTROSCOPIC STUDIES ON THE QUERCETIN/(2-HYDROXYPROPYL)-B-CYCLODEXTRIN INTERACTIONS 56
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 56
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin 56
Totale 7.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020360 0 0 0 0 0 0 0 0 0 131 214 15
2020/20211.215 151 4 263 35 24 139 8 136 34 110 129 182
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20252.091 48 51 59 192 113 67 40 694 756 71 0 0
Totale 10.220